Wisconsin Alumni Research Foundation

Therapeutics & Vaccines
Therapeutics Vaccines
Botulinum Neurotoxin A Receptor And The Use Thereof
WARF: P05381US

Inventors: Edwin Chapman, Min Dong


The Invention
The present invention is based on the identification of synaptic vessel glycoprotein SV2 as the BoNT/A receptor and the further identification of various BoNT/A-binding fragments of SV2. The disclosure here provides new tools for diagnosing and treating botulism.
Additional Information
For More Information About the Inventors
For current licensing status, please contact Rafael Diaz at [javascript protected email address] or 608-960-9847

WARF